Hours instead of days

Today’s time-consuming diagnosis of sepsis leads to prolonged patient hospitalization, increased mortality, and an overuse of broad-spectrum antibiotics. Q-linea’s fully automated ASTar™ system cuts the diagnostic time for sepsis and deliver clinically-actionable results in hours instead of days.


Rapid AST directly from blood culture

ASTar™ is a fully automated, “load-and-go”, instrument for Antibiotic Susceptibility Testing (AST), giving a susceptibility profile within three to six hours directly from a positive blood culture. ASTar shortens time to result, enabling early use of antibiotics specifically targeting the disease causing pathogen.


Sepsis – a growing threat to public health

Sepsis is a global health problem, afflicting as many as 30 million people every year. Sepsis is a life-threatening condition, every hour that effective treatment is delayed may have a devastating effect. ASTar will shorten the time to correct antibiotic treatment with more than 24 hours.


  • Stabilization notice and end of the stabilization period

    January 4, 2019
    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES
    Read more
  • Change in the number of shares and votes in Q-linea AB

    December 28, 2018
    Q-linea AB (publ) (”Q-linea” or ”the Company”), today announced that the number of shares and votes in Q-linea has increased during the...
    Read more
  • Stabilization notice

    December 18, 2018
    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES Carnegie Investment Bank AB (publ) (”Carnegie”) notifies that stabilization measures have been undertaken in Q-linea AB (publ) (”Q-linea” or the “Company”) shares traded on Nasdaq Stockholm.
    Read more

Do you want to know more? Subscribe to our mailing list!